Clinical Trials Browser

Phase EARLY_PHASE1 × trastuzumab deruxtecan × 30 days × Clear all

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms